This profile is for informational purposes only and is not medical advice. Consult a healthcare professional before use. See full terms.
Emoxypine (Mexidol)
A Russian-developed neuroprotective antioxidant with combined anxiolytic, anti-stress, and cognitive-enhancing properties - modulates GABA receptors and protects neuronal membranes from oxidative damage.
Benefits
What is Emoxypine (Mexidol)?
Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine) is a synthetic compound developed at the Institute of Biochemical Physics of the Russian Academy of Sciences. Marketed in Russia as Mexidol (emoxypine succinate) since the late 1990s, it is prescribed for a wide range of neurological conditions including acute cerebrovascular accidents (stroke), anxiety disorders, cognitive impairment, alcohol withdrawal, and vegetovascular dystonia. It is one of the most widely prescribed neuroprotective drugs in Russia.
Emoxypine's pharmacological profile is unusual in combining potent membrane antioxidant activity with GABA-A receptor modulation. A 2019 systematic review published in Zhurnal Nevrologii i Psikhiatrii analysed 26 clinical studies and concluded that emoxypine improved cognitive function, reduced anxiety, and enhanced quality of life in patients with chronic cerebral ischaemia. Its mechanism centres on protecting neuronal membrane lipids from peroxidation - it directly embeds in the lipid bilayer and scavenges peroxyl radicals at the membrane level, preserving membrane fluidity and receptor function. Simultaneously, it positively modulates GABA-A receptors at the benzodiazepine binding site, producing anxiolytic effects without the sedation, tolerance, or dependence associated with benzodiazepines. It also inhibits free radical stages of mitochondrial oxidative phosphorylation, enhances mitochondrial energy production, and increases the ratio of reduced to oxidised glutathione in brain tissue.
- Membrane antioxidant: Incorporates directly into lipid bilayers and scavenges lipid peroxyl radicals at the membrane level, preserving neuronal membrane integrity and fluidity
- GABA-A receptor modulation: Positively modulates GABA-A receptors at the benzodiazepine binding site, producing anxiolysis without sedation, tolerance, or dependence
- Mitochondrial protection: Inhibits pathological free radical formation during mitochondrial electron transport, maintaining ATP production under stress
- Glutathione preservation: Increases the GSH/GSSG ratio (reduced to oxidised glutathione) in brain tissue, enhancing endogenous antioxidant defences
- Dopamine modulation: Influences dopaminergic neurotransmission, contributing to improved motivation and cognitive clarity
- Standard oral dosage: 125-250 mg, 2-3 times per day (250-750 mg total daily)
- Russian clinical protocols: Typical treatment courses of 2-6 weeks, often starting with intravenous dosing (200-500 mg/day) before transitioning to oral maintenance
- Onset: Anxiolytic effects may be noticed within days. Cognitive improvements typically develop over 2-4 weeks
- Duration: Effects last 4-6 hours per dose. Divide daily intake into 2-3 administrations
- Cycling: Russian clinical guidelines recommend treatment courses of 2-6 weeks with breaks between courses
- Russian clinical use: Extensive prescribing history in Russia with a favourable safety profile reported across thousands of patients
- Limited Western data: No large Western-standard randomised controlled trials exist. Evidence is primarily from Russian clinical studies
- Mild side effects: Nausea, drowsiness, dry mouth, and allergic reactions (rash) are the most commonly reported side effects
- Blood pressure: May lower blood pressure. Use with caution in individuals with hypotension or those taking antihypertensive medications
- Not widely available: Primarily available through Russian pharmacies or international online vendors. Quality verification is important
Natural Sources & Forms
- Mexidol tablets: 125 mg tablets of emoxypine succinate, the standard pharmaceutical form available from Russian pharmacies
- International online vendors: Available from some international pharmaceutical retailers, though authenticity should be verified
- Powder: Raw emoxypine succinate powder available from some research chemical suppliers
Frequently Asked Questions
A Russian-developed neuroprotective antioxidant with combined anxiolytic, anti-stress, and cognitive-enhancing properties - modulates GABA receptors and protects neuronal membranes from oxidative damage.
The key benefits of Emoxypine (Mexidol) include: Anxiety & Calm, Cognitive Enhancement, Longevity, Memory, Mood, Stress Relief.
Membrane antioxidant: Incorporates directly into lipid bilayers and scavenges lipid peroxyl radicals at the membrane level, preserving neuronal membrane integrity and fluidity GABA-A receptor modulation: Positively modulates GABA-A receptors at the benzodiazepine binding site, producing anxiolysis without sedation, tolerance, or dependence Mitochondrial protection: Inhibits pathological free radical formation during mitochondrial electron transport, maintaining ATP production under stress Glutathione preservation: Increases the GSH/GSSG ratio (reduced to oxidised glutathione) in brain tissue, enhancing endogenous antioxidant defences Dopamine modulation: Influences dopaminergic neurotransmission, contributing to improved motivation and cognitive clarity
Standard oral dosage: 125-250 mg, 2-3 times per day (250-750 mg total daily) Russian clinical protocols: Typical treatment courses of 2-6 weeks, often starting with intravenous dosing (200-500 mg/day) before transitioning to oral maintenance Onset: Anxiolytic effects may be noticed within days. Cognitive improvements typically develop over 2-4 weeks Duration: Effects last 4-6 hours per dose. Divide daily intake into 2-3 administrations Cycling: Russian clinical guidelines recommend treatment courses of 2-6 weeks with breaks between courses
Russian clinical use: Extensive prescribing history in Russia with a favourable safety profile reported across thousands of patients Limited Western data: No large Western-standard randomised controlled trials exist. Evidence is primarily from Russian clinical studies Mild side effects: Nausea, drowsiness, dry mouth, and allergic reactions (rash) are the most commonly reported side effects Blood pressure: May lower blood pressure. Use with caution in individuals with hypotension or those taking antihypertensive medications Not widely available: Primarily available through Russian pharmacies or international online vendors. Quality verification is important
Overall Rating
Log in to rate this nootropic.
Comments
Log in to leave a comment.
No comments yet. Be the first to share your experience!